Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DWOY01
|
|||
| Drug Name |
RTA 901
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diabetic neuropathy [ICD-11: 8C0Z] | Phase 1 | [1] | |
| Company |
Reata Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Heat shock protein 90 (HSP90) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02666963) A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Reata Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.